Clinical Trial Site

New Taipei City 235041

4 studies enrolling now · 4 studies all time

What they study most

ATTR Amyloidosis, Atypical Hemolytic-Uremic Syndrome, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Transthyretin Amyloidosis With Cardiomyopathy, Transthyretin-Mediated Amyloidosis

Studies at this site

• TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Recruiting now
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis) — Recruiting now
• Atypical Hemolytic-Uremic Syndrome (aHUS) Registry — Recruiting now